Pharma firm sets 2050 climate plan favoring PPAs over offsets
![Photo: BeGreen](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12738341.ece/ALTERNATES/schema-16_9/doc7ed7982g00p1ezy1tjxm.jpg)
Lundbeck's goal to become carbon neutral by 2050 heavily leans on the global Paris Agreement, but the pharmaceutical companies plans to reach this target before then, says Lundbeck CEO Deborah Dunsire in the wake of the company presenting its new climate plan.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Statkraft takes U-turn on offshore wind
For subscribers
PPA market set record in 2020
For subscribers